Cube Labs SpA (MIL:CUBE) Accounts Receivable : €4.30 Mil (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cube Labs SpA Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Cube Labs SpA's accounts receivables for the quarter that ended in Jun. 2023 was €4.30 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Cube Labs SpA's Days Sales Outstanding for the quarter that ended in Jun. 2023 was 1,043.07.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Cube Labs SpA's Net-Net Working Capital per share for the quarter that ended in Jun. 2023 was €0.06.

Cube Labs SpA Accounts Receivable Historical Data

The historical data trend for Cube Labs SpA's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cube Labs SpA Accounts Receivable Chart

Cube Labs SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Receivable

1.55

0.67

1.52

2.31

3.39

Cube Labs SpA Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Accounts Receivable	Get a 7-Day Free Trial			-	2.31	2.83	3.39	4.30

Cube Labs SpA Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Cube Labs SpA Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Cube Labs SpA's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4.298	/	0.752	*	91
=	1,043.07

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Cube Labs SpA's accounts receivable are only considered to be worth 75% of book value:

Cube Labs SpA's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(2.407	+	0.75 * 4.298	+	0.5 * 0	-	4.55
-	0	-	0)	/	17.2463
=	0.06

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Cube Labs SpA Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Cube Labs SpA's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cube Labs SpA (MIL:CUBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Cube Labs SpA (MIL:CUBE) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Giulio Caccini, 1, Rome, ITA, 00186

Website

https://cube-labs.com

Cube Labs SpA operates as a venture builder that enables innovation in the healthcare technology space. The company is engaged in attracting sources of financing and providing entrepreneurial and operational support to the companies to develop healthcare technologies for the market.